Antihypertensive Drugs Market (By Therapeutic Class: Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, Others; By Type: Primary Hypertension, Secondary Hypertension; By Distribution Channel: E-commerce Websites & Online Drug Stores, Retail Pharmacy, Hospital Pharmacy, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Antihypertensive Drugs
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Antihypertensive Drugs Market By Therapeutic Class
     1.2.2.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison By Therapeutic Class(2020-2027)
     1.2.2.2. Global Antihypertensive Drugs Market Revenue Share By Therapeutic Class in 2019
     1.2.2.3. Calcium Channel Blockers
     1.2.2.4. Beta-adrenergic Blockers
     1.2.2.5. Renin Inhibitors
     1.2.2.6. ACE Inhibitors
     1.2.2.7. Vasodilators
     1.2.2.8. Diuretics
     1.2.2.9. ARBs
     1.2.2.10. Others
   1.2.3. Antihypertensive Drugs Market By Type
     1.2.3.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison By Type (2020-2027)
     1.2.3.2. Global Antihypertensive Drugs Market Revenue Share By Type in 2019
       1.2.3.2.1. Primary Hypertension
       1.2.3.2.2. Secondary Hypertension
   1.2.4. Antihypertensive Drugs Market By Distribution Channel
     1.2.4.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison By Distribution Channel(2020-2027)
     1.2.4.2. Global Antihypertensive Drugs Market Revenue Share By Distribution Channel in 2019
       1.2.4.2.1. E-commerce Websites & Online Drug Stores
       1.2.4.2.2. Retail Pharmacy
       1.2.4.2.3. Hospital Pharmacy
       1.2.4.2.4. Others
   1.2.5. Antihypertensive Drugs Market By Geography
     1.2.5.1. Global Antihypertensive Drugs Market Revenue and Growth Rate Comparison by Geography (2020-2027)
     1.2.5.2. North America Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
     1.2.5.3. Europe Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
     1.2.5.4. Asia-Pacific Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
     1.2.5.5. Latin America Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)
     1.2.5.6. Middle East and Africa (MEA)Antihypertensive Drugs Market Revenue and Growth Rate(2020-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING ANTIHYPERTENSIVE DRUGS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Antihypertensive Drugs Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Antihypertensive Drugs Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Antihypertensive Drugs Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Antihypertensive Drugs Major Manufacturers in 2019

CHAPTER 4. ANTIHYPERTENSIVE DRUGS MARKET BY THERAPEUTIC CLASS
4.1. Global Antihypertensive Drugs Revenue By Therapeutic Class
4.2. Calcium Channel Blockers
   4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Beta-adrenergic Blockers
   4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. Renin Inhibitors
   4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. ACE Inhibitors
   4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.6. Vasodilators
   4.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.7. Diuretics
   4.7.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.7.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.8. ARBs
   4.8.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.8.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.9. Others
   4.9.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.9.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 5. ANTIHYPERTENSIVE DRUGS MARKET BY TYPE
5.1. Global Antihypertensive Drugs Revenue By Type
5.2. Primary Hypertension
   5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Secondary Hypertension
   5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 6. ANTIHYPERTENSIVE DRUGS MARKET BY DISTRIBUTION CHANNEL
6.1. Global Antihypertensive Drugs Revenue By Distribution Channel
6.2. E-commerce Websites & Online Drug Stores
   6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Retail Pharmacy
   6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Hospital Pharmacy
   6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.5. Others
   6.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 7. NORTH AMERICA ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
7.1. North America Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. North America Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. U.S.
   7.3.1. U.S. Antihypertensive Drugs Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   7.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   7.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)

CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Europe Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   8.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   8.6.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.6.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   8.7.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.7.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)

CHAPTER 9. ASIA-PACIFIC ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
9.1. Asia-Pacific Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Asia-Pacific Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   9.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   9.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   9.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   9.6.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.6.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   9.7.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.7.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   9.8.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.8.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)

CHAPTER 10. LATIN AMERICA ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
10.1. Latin America Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Latin America Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   10.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   10.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   10.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA ANTIHYPERTENSIVE DRUGS MARKET BY COUNTRY
11.1. Middle East & Africa Antihypertensive Drugs Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Middle East & Africa Antihypertensive Drugs Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Therapeutic Class, 2020 - 2027 ($Million)
   11.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Distribution Channel, 2020 - 2027 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Johnson and Johnson Ltd.
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Product Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Merck KGaA
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Product Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Boehringer Ingelheim GmbH
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Product Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Bayer AG
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Product Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. AstraZeneca plc
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Product Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Pfizer, Inc.
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Product Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Takeda Pharmaceutical Co, Ltd.
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Product Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Sanofi S.A.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Product Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Daiichi Sankyo Company
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Product Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Others
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Product Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope